BRIEF-Amgen, Allergan submit biosimilar biologics license application for ABP 215 to U.S. FDA
November 15, 2016 at 16:07 PM EST
* Amgen Inc - BLA submission includes analytical, pharmacokinetic and clinical data, as well as pharmacology and toxicology data
